Tate & Lyle plc

LON-TATE
London Stock Exchange
Consumer Staples Packaged Foods
Global Rank
#4659
Country Rank
#142
Market Cap
3.13 B
Price
709.71
Change (%)
0.28%
Volume
2.23 M

Tate & Lyle plc's latest marketcap:

3.13 B

As of 08/02/2025, Tate & Lyle plc's market capitalization has reached $3.13 B. According to our data, Tate & Lyle plc is the 4659th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 3.13 B
Revenue (ttm) 2.31 B
Net Income (ttm) 189.88 M
Shares Out 441.67 M
EPS (ttm) 0.46
Forward PE 11.11
Ex-Dividend Date 06/19/2025
Earnings Date 11/06/2025
Market Cap Chart
Data Updated: 08/02/2025

Tate & Lyle plc's yearly market capitalization.

Tate & Lyle plc has seen its market value drop from £2.8 B to £2.36 B since 2014, representing a total decrease of 15.59% and an annual compound decline rate (CAGR) of 1.59%.
Date Market Cap(£) Market Cap(USD) Change (%) Global Rank
08/02/2025 £2.36 B $3.13 B -17.34% 4659
12/31/2024 £2.86 B $3.58 B 9.28% 3839
12/29/2023 £2.62 B $3.34 B -7.44% 3959
12/30/2022 £2.83 B $3.42 B -7.84% 3655
12/31/2021 £3.07 B $4.15 B -1.67% 3725
12/31/2020 £3.12 B $4.27 B -11.41% 3210
12/31/2019 £3.53 B $4.68 B 14.93% 2494
12/31/2018 £3.07 B $3.91 B -5.83% 2474
12/29/2017 £3.26 B $4.4 B -0.76% 2583
12/30/2016 £3.28 B $4.05 B 18.18% 2275

Company Profile

Tate & Lyle plc Overview

Tate & Lyle plc, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries across multiple regions, including:

  • North America
  • Asia, Middle East, and Africa
  • Latin America
  • Europe

Business Segments

The company operates through three key segments:

  • Food & Beverage Solutions
  • Sucralose
  • Primary Products Europe & Primient

Product Offerings

Tate & Lyle delivers a diverse range of products, including:

  • Dairy products, soups, sauces, and dressings
  • Bakery products and snacks
  • Texturants
  • Sweeteners (e.g., high fructose corn syrup, dextrose)
  • Industrial starches and acidulants
  • Corn gluten feed, meal, and corn oil

Company Background

Founded in 1903, Tate & Lyle is headquartered in London, United Kingdom.

Frequently Asked Questions

  • What is Tate & Lyle plc's (LON-TATE) current market cap?
    As of 08/02/2025, Tate & Lyle plc (including the parent company, if applicable) has an estimated market capitalization of $3.13 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Tate & Lyle plc global market capitalization ranking is approximately 4659 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.